Heart, Vascular & Thoracic
VITALS
Volumes and outcomes from a sampling of centers in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute
For more data like this, visit clevelandclinic.org/hvtioutcomes
and clevelandclinic.org/e15
30-day mortality after esophagectomy for cancer (N = 197), vs. 4.0% Society of Thoracic Surgeons (STS) predicted mortality
1.6%
Mortality for general thoracic operations, vs. 2.3% expected
mortality (Vizient)
1.2%
Number of general thoracic operations
1,916
2021 DATA HIGHLIGHTS
THORACIC SURGERY
Proportion of thymectomy/thymic mass resections completed robotically (N = 43)
79%
Proportion of all lobectomies for stage I lung cancer (N = 124) that used video/robot-assisted thoracoscopic surgery
95%
Number of robotically assisted thoracic surgery procedures
284
USE OF MINIMALLY INVASIVE PROCEDURES IN 2021
Of 183 participants in this STS category, Cleveland Clinic was one of 27 that achieved a 3-star rating.
The following stats are from the STS General Thoracic Surgery Database (3-year period ending December 2021):
STS QUALITY RATINGS
Lobectomy for Lung Cancer — Composite Overall Quality Rating
Eligible
procedures
Participant
score
STS mean
participant score
Participant
rating
(highest)
98.10%
98.65%
504
Of 192 participants in this STS category, Cleveland Clinic was one of 28 that achieved a 3-star rating.
(highest)
98.31%
98.83%
738
Participant
rating
STS mean
participant score
Participant
score
Eligible
procedures
Lung Cancer Resection — Composite Overall Quality Rating
Of 99 participants in this STS category, Cleveland Clinic was one of 15 that achieved a 3-star rating.
(highest)
91.47%
95.40%
194
Participant
rating
STS mean
participant score
Participant
score
Eligible
procedures
Esophagectomy — Composite Overall Quality Rating
70.8%
87.65%
Observed
Lung Transplant Patient Survival Rates
30-day survival rate following EVLP lung transplant
96.7%
Number of lung transplants after ex vivo lung perfusion (EVLP)
30
Number of lung transplants performed
96
2021 DATA HIGHLIGHTS
LUNG TRANSPLANTATION
Number of multiorgan lung transplant cases
(3 lung/liver, 1 heart/lung)
4
3-year survival (N = 283)
1-year survival (N = 258)
74.14%
88.59%
Expected
75.09%
89.46%
National
7/1/2016-12/31/2018
1/1/2019-3/12/2020,
6/13/2020-6/30/2021
Report period
Source: Scientific Registry of Transplant Recipients (SRTR) data release of 7/6/2022
Ex vivo lung perfusion
100
0
2018
2019
2020
2021
200
300
400
500
600
700
12.23%
(95% CI, 11.20%-13.32%)
4.35%
(95% CI, 0.11%-21.95%)
STS
benchmark**
Cleveland
Clinic
COMPLEX CASES — STAT mortality category 5
0
5
10
15
6.15%
(95% CI, 5.83%-6.48%)
3.16%
(95% CI, 1.45%-5.91%)
STS
benchmark**
Cleveland
Clinic
COMPLEX CASES — STAT mortality category 4
0
5
10
15
2.72%
(95% CI, 2.61%-2.82%)
1.38%
(95% CI, 0.85%-2.09%)
STS
benchmark**
Cleveland
Clinic
OVERALL (for all STAT mortality categories)
0
1
2
3
RISK-ADJUSTED MORTALITY — 7/1/2016-6/30/2020
* Adult numbers do not include bicuspid and unicuspid aortic valves, myectomy, or surgery for
connective tissue disorders.
** Society of Thoracic Surgeons Congenital Heart Surgery Database
PEDIATRIC & ADULT CONGENITAL HEART SURGERY*
508
545
549
624
ANNUAL VOLUMES
Volume
Mortality
0
10
20
30
40
Coarc
Glenn
TOF
VSD
34
11
26
35
VOLUMES AND UNADJUSTED MORTALITY FOR BENCHMARK PROCEDURES — 1/1/2018-12/31/2021
AVC
Fontan
Norwood
18
18
24
0
0
1
0
1
0
0
VSD = ventricular septal defect; TOF = tetralogy of Fallot;
AVC = atrioventricular canal defect; Coarc = coarctation of the aorta